Treatment of Breast Cancer

Surgery

Surgery is one primary treatment for breast cancer. Two of the more common types of surgery are the
modified mastectomy—which removes the breast tissue and some lymph nodes—and the lumpectomy—
which involves removing the tumor locally. Radical mastectomy, which removes the muscle underlying the
breast in addition to the breast tissue and lymph nodes, is used infrequently now. The long-term survival
rates of patients treated with lumpectomy alone or lumpectomy plus radiation therapy are equivalent to
those achieved with modified mastectomy.1, 2

These operations are usually accompanied by the removal of some regional lymph nodes to determine if the
disease has spread beyond the breast. The presence of malignant cells in the lymph nodes as well as other
factors will help determine the need for and course of subsequent therapy.

Radiation Therapy

The precision and effectiveness of radiation therapy has improved dramatically over the years. Years ago,
when radiation doses were higher and less precise, women with breast cancer who were treated with
radiation had significantly increased risks of lung cancer or heart damage. Current radiation therapy,
however, involves a much reduced risk and is essential as adjuvant therapy to lumpectomy and may be
useful adjuvant therapy to modified mastectomy.1

Chemotherapy

A few “cytotoxic” drugs are used in various combinations to treat breast cancer. Research has established
that combinations of these drugs are more effective than just one drug alone. After the disease has become
resistant to the first-line drugs, about 20% to 30% of patients will respond to second-line drugs.1

Taxol and taxotere are also used for the treatment of breast cancer that has recurred or progressed despite
treatment. Chemotherapy followed by radiation therapy may result in a higher 5-year relative survival than
radiation therapy followed by chemotherapy among women at risk of metastatic disease.3

Hormone Therapy

Hormone therapy adds to or interferes with the action of a patient’s hormones. Women whose breast
cancers test positive for estrogen or progesterone receptors may be given this type of treatment to block the
effects of estrogens on the growth of malignant cells in breast tissue. Tamoxifen, progestins,
aminoglutethimide, estrogens, and androgens are usually more effective in postmenopausal patients than in
premenopausal patients.

Premenopausal women may first receive tamoxifen or have their ovaries removed, and later receive
progestins or aminoglutethimide if they have responded to tamoxifen or ovarian surgery.


References:

  1. Henderson IC. Breast Cancer. In: Murphy GP, Lawrence WL, Lenhard RE (eds). Clinical Oncology. Atlanta, GA: American Cancer Society; 1995:198-219.
  2. Harris JR, Recht A. Conservative surgery and radiotherapy. In: Harris JR, Hellman S, Henderson IC,
    Kinne DW (eds). Breast Diseases. 2nd ed. Philadelphia, PA: JB Lippincott Co.; 1991:388-419.
  3. Recht A, Come SE, Henderson IC, Gelman RS, et al. The sequencing of chemotherapy and
    radiation therapy after conservative surgery for early-stage breast cancer. NEJM. 1996;334:1356-
    1361.

Download this articleClick here to download this article


  • Share/Bookmark